Semaglutide: Science, Society, and Ethical Implications

Created using ChatSlide

This presentation explores semaglutide, a GLP-1 receptor agonist, detailing its mechanism of action, neuropsychopharmacological effects, and clinical applications in type 2 diabetes and obesity management. It delves into societal and ethical considerations, including drug costs, weight stigma, and misuse concerns. Concluding on a forward-looking note, it reflects on media attention and its role in shaping healthcare adaptations.